Interstitial Lung Disease Associated with Lung Cancer: A Case-Control Study.

Area of Science:

• Pulmonology
• Oncology

Background:

• Interstitial lung disease (ILD) is suspected to increase lung cancer (LC) risk and negatively impact prognosis.
• The prevalence of ILD in LC patients and its prognostic significance require further clarification.

Purpose of the Study:

• To determine the frequency of ILD in a cohort of LC patients.
• To compare characteristics of LC patients with and without ILD (LC-ILD vs. LC-noILD).
• To evaluate the impact of ILD on LC prognosis using a case-control analysis.

Main Methods:

• Retrospective, observational cohort study of 906 LC patients diagnosed over two years.
• Comparison of clinical characteristics between LC-ILD and LC-noILD groups.
• Case-control study matching three LC-noILD patients to each LC-ILD patient for prognostic analysis.

Main Results:

• 49 (5.4%) of LC patients had concurrent ILD.
• LC-ILD patients were more frequently male and had shorter median overall survival (9 vs. 17.5 months).
• Multivariate analysis identified ILD (HR 1.79) as an independent risk factor for LC mortality, while standard-of-care management was protective (HR 0.49).

Conclusions:

• Approximately 5% of new lung cancer diagnoses are associated with ILD.
• ILD is a significant prognostic factor for lung cancer patients.
• ILD should be considered in the management of lung cancer; further research is needed for optimal therapeutic strategies in LC-ILD patients.